Cangene Corporation (CC:CNJ) Announces Amendment to Normal Course Issuer Bid
11/12/2009 11:27:07 AM
More...
|
Cangene Corporation (CC:CNJ) Acquires U.S. Commercialization Rights for HepaGam B(R) from Apotex Corp. (JOBS); Apotex to Get $7 Million Upfront
10/20/2009 7:31:45 AM
More...
|
Cangene Corporation (CC:CNJ) Opts to Exit European Market with WinRho(R) SDF
7/31/2009 9:33:16 AM
More...
|
Sparta Systems, Inc.'s TrackWise(R) Solution Delivers Workforce Training and Learning Initiatives for Cangene Corporation (CC:CNJ)
7/13/2009 9:35:36 AM
More...
|
Cangene Corporation (CC:CNJ) Acquires Twinstrand Therapeutics
7/8/2009 6:48:20 AM
More...
|
Upfront Chromatography Licenses Use of EBA Technology to Cangene Corporation (CC:CNJ)
6/17/2009 11:22:09 AM
More...
|
Cangene Corporation (CC:CNJ) Receives First Overseas Approval for HepaGam B(R)
6/5/2009 7:23:26 AM
More...
|
Maxygen, Inc. (MAXY) Announces MAXY-G34 Licensing Arrangement with Cangene Corporation (CC:CNJ) for Acute Radiation Syndrome
5/8/2009 7:55:50 AM
More...
|
Cangene Corporation (CC:CNJ) - U.S. Government Replaces Original RFP on Acute Radiation Syndrome
1/20/2009 3:07:32 PM
More...
|
Cangene Corporation (CC:CNJ) Announces Strong Financial Results for Fiscal 2008 with Net Income Up 194% to $29.6 Million or 42 Cents Per Share
10/17/2008 3:19:57 PM
More...
|
|